Improving trial diversity is one of the most important issues in clinical research today, but defining diversity is more than just pointing to the usual underserved racial and ethnic minority groups. What’s required is a deeper dive into the factors that may keep people from participating in clinical trials. Read More
Much of the conversation about research data these days centers on how important it is to protect sensitive patient information, particularly as technology makes data-sharing easier at the same time regulatory agencies are requiring sponsors and researchers to share the results of their trials. Read More
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) will institute a streamlined trial review process next year that will allow sponsors to submit a single application for both trial authorization and ethics committee approval. Read More
All systems are go for the EU’s Clinical Trials Information System (CTIS), with the European Commission disclosing that the IT technology platform will be launched as planned on Jan. 31. Read More
